162 related articles for article (PubMed ID: 35365936)
1. Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE).
Aonuma K; Ando K; Kusano K; Asai T; Inoue K; Inamura Y; Ikeda T; Mitsuhashi T; Murohara T; Nishii N; Nogami A; Shimizu W; Beaudoint C; Simon T; Kayser T; Azlan H; Tachapong N; Chan JY; Kutyifa V; Sakata Y;
ESC Heart Fail; 2022 Jun; 9(3):1584-1596. PubMed ID: 35365936
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the HINODE study: Heart failure indication and sudden cardiac death prevention trial Japan.
Yamasaki H; Ando K; Ikeda T; Mitsuhashi T; Murohara T; Nishii N; Nogami A; Sakata Y; Shimizu W; Simon T; Beaudoint C; Kayser T; Kutyifa V; Aonuma K
J Arrhythm; 2021 Aug; 37(4):1031-1037. PubMed ID: 34386129
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
4. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
[TBL] [Abstract][Full Text] [Related]
5. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
Gold MR; Lambiase PD; El-Chami MF; Knops RE; Aasbo JD; Bongiorni MG; Russo AM; Deharo JC; Burke MC; Dinerman J; Barr CS; Shaik N; Carter N; Stoltz T; Stein KM; Brisben AJ; Boersma LVA;
Circulation; 2021 Jan; 143(1):7-17. PubMed ID: 33073614
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
7. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
9. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
10. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
12. Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review.
Barra S; Providência R; Narayanan K; Boveda S; Duehmke R; Garcia R; Leyva F; Roger V; Jouven X; Agarwal S; Levy WC; Marijon E
Eur Heart J; 2020 Jun; 41(21):1976-1986. PubMed ID: 31750896
[TBL] [Abstract][Full Text] [Related]
13. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
[TBL] [Abstract][Full Text] [Related]
17. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
[TBL] [Abstract][Full Text] [Related]
18. Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy.
Linhart M; Doltra A; Acosta J; Borràs R; Jáuregui B; Fernández-Armenta J; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Soto-Iglesias D; Villuendas R; Perea RJ; Ortiz JT; Bosch X; Auricchio A; Mont L; Berruezo A
Europace; 2020 Sep; 22(9):1391-1400. PubMed ID: 32898254
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
